Finn Guo: Driving a New Era of Accessible Gene Therapy for Hemophilia in China
Finn Guo, Director of Information Research at Illness Challenge Foundation, shared on LinkedIn:
”From launching the project in March to completing the research report ‘Payment Mechanism and Global Strategies for Innovative Hemophilia Therapies’ in June — officially presented at the International Hemophilia Conference.
We started with patient surveys to truly understand the challenges, drew insights from international best practices, and finally developed practical solution frameworks.
While the scheme is still a long way from real-world implementation, I’m truly excited that the rapid progress in China’s domestic gene therapy for hemophilia — combined with current market pricing — is set to usher China into a new era of accessible gene therapy.
Hope is on the horizon.”
Stay updated with Hemostasis Today.
-
Sep 13, 2026, 11:26Tareq Abadl: When Good Samples Give Bad Numbers – Spotting EDTA Contamination in the Lab
-
Sep 13, 2026, 11:22Amanda Unsworth: Gratitude and Next Steps as Leadership Transitions at The Platelet Society
-
Sep 13, 2026, 11:18Mary Cushman: Covering Associations of Antiphospholipid Antibodies with Stroke
-
Sep 13, 2026, 11:13Mavis Agnes Kisakye: How Community Partnerships Are Driving Opportunity for Youths with Bleeding Disorders
-
Sep 13, 2026, 11:07Dianne E. van der Wal: Transforming Science into Art – The Launch of The Life, Function and Death of Platelets
-
Sep 13, 2026, 10:18Daniel Victor Ortigoza: Understanding Stroke, Risk Factors and Prevention
-
Sep 13, 2026, 08:13Selina Olwanda Ogweno: Expanding Access to Sickle Cell Care for Children and Young People
-
Sep 13, 2026, 08:02Alexandra Rickard: One Donation Can Make All the Difference
-
Sep 13, 2026, 07:41Global Study Defines ISTH BAT Reference Ranges in Children and Adolescents – JTH